| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |